These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 31216866
21. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study. Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F. Lipids Health Dis; 2010 Jan 23; 9():6. PubMed ID: 20096127 [Abstract] [Full Text] [Related]
23. Lipid-related markers and cardiovascular disease prediction. Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G, D'Agostino RB, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gómez-de-la-Cámara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J. JAMA; 2012 Jun 20; 307(23):2499-506. PubMed ID: 22797450 [Abstract] [Full Text] [Related]
24. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Robinson JG, Wang S, Jacobson TA. Am J Cardiol; 2012 Nov 15; 110(10):1468-76. PubMed ID: 22906895 [Abstract] [Full Text] [Related]
31. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Mariosa D, Hammar N, Malmström H, Ingre C, Jungner I, Ye W, Fang F, Walldius G. Ann Neurol; 2017 May 20; 81(5):718-728. PubMed ID: 28437840 [Abstract] [Full Text] [Related]
35. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP, PREVEND Study Group. J Clin Lipidol; 2013 May 20; 7(1):56-64. PubMed ID: 23351584 [Abstract] [Full Text] [Related]
36. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. Pencina MJ, D'Agostino RB, Zdrojewski T, Williams K, Thanassoulis G, Furberg CD, Peterson ED, Vasan RS, Sniderman AD. Eur J Prev Cardiol; 2015 Oct 20; 22(10):1321-7. PubMed ID: 25633587 [Abstract] [Full Text] [Related]
40. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB. Diabetes Care; 2004 Aug 20; 27(8):1991-7. PubMed ID: 15277429 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]